Profile data is unavailable for this security.
About the company
Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The Company operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.
- Revenue in HKD (TTM)3.26bn
- Net income in HKD-26.78m
- Incorporated2021
- Employees485.00
- LocationFangzhou IncFloor 1-2, 4th Street, Building SKehui Jingu, No. 99, Science Avenue, LuGUANGZHOU ChinaCHN
- Websitehttps://investors.jianke.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical System Network Co Ltd | 6.61bn | 42.32m | 856.13m | 3.86k | 19.30 | 0.9421 | 3.89 | 0.1295 | 28.29 | 28.29 | 4,419.52 | 579.57 | 1.65 | 10.15 | 12.93 | 33,465,280.00 | 1.11 | 2.84 | 1.90 | 4.35 | 40.81 | 41.46 | 0.6735 | 1.68 | 0.6786 | 8.07 | 0.6557 | 18.79 | 6.09 | 3.06 | -32.15 | -- | 16.17 | 3.71 |
| Green Cross Health Ltd | 2.49bn | 82.62m | 1.00bn | 248.00 | 11.75 | 1.23 | 5.12 | 0.4022 | 0.1217 | 0.1217 | 3.67 | 1.16 | 1.35 | 6.70 | 21.09 | -- | 5.55 | 5.53 | 7.53 | 7.95 | 57.46 | 59.21 | 4.12 | 4.18 | 0.5702 | 4.80 | 0.4313 | 41.79 | 3.94 | -1.63 | 32.76 | 3.44 | -4.28 | 8.45 |
| Dingdang Health Technology Group Ltd | 5.35bn | -388.68m | 1.16bn | 2.27k | -- | 0.62 | -- | 0.2172 | -0.2947 | -0.2947 | 4.08 | 1.42 | 1.61 | 5.00 | 39.68 | 2,262,903.00 | -11.63 | -46.70 | -17.31 | -67.25 | 33.89 | 32.52 | -7.24 | -30.22 | 1.73 | -- | 0.1358 | -- | -3.87 | 29.63 | -66.73 | -- | -1.86 | -- |
| Kimia Farma Tbk PT | 4.22bn | -278.97m | 1.37bn | 9.64k | -- | 0.9086 | -- | 0.3248 | -143.10 | -143.10 | 1,977.01 | 583.30 | 0.5728 | 3.56 | 5.39 | 896,722,800.00 | -5.62 | -3.72 | -10.72 | -7.04 | 32.24 | 33.09 | -9.81 | -6.30 | 0.3837 | -0.9365 | 0.692 | -- | 0.6799 | 1.12 | 57.12 | -- | -25.74 | -- |
| Sipai Health Technology Co, Ltd | 3.87bn | -359.10m | 1.63bn | 2.95k | -- | 1.47 | -- | 0.4212 | -0.571 | -0.571 | 6.22 | 1.50 | 1.44 | 14.81 | 7.29 | 1,193,200.00 | -15.51 | -52.80 | -28.98 | -79.72 | 9.74 | 8.16 | -10.75 | -34.60 | 1.67 | -- | 0.0252 | -- | -3.11 | 34.45 | -26.57 | -- | -8.64 | -- |
| JZJ Chain Drugstore Corp | 10.30bn | 144.86m | 3.60bn | 17.63k | 24.76 | 1.21 | -- | 0.3493 | 0.8305 | 0.8305 | 59.09 | 16.99 | 0.8898 | 2.10 | 15.58 | 516,114.80 | 1.27 | 4.24 | 2.67 | 8.13 | 35.31 | 35.31 | 1.43 | 4.12 | 0.3453 | 2.20 | 0.6304 | 48.72 | 2.23 | 21.34 | -69.08 | -5.29 | 15.00 | -- |
| Fangzhou Inc | 3.26bn | -26.78m | 3.69bn | 485.00 | -- | 21.02 | -- | 1.13 | -0.0199 | -0.0199 | 2.44 | 0.1266 | 4.29 | 13.75 | 74.78 | 6,670,105.00 | -3.53 | -- | -22.44 | -- | 18.02 | -- | -0.8227 | -- | 0.8734 | 0.1636 | 0.1956 | -- | 11.22 | -- | -334.42 | -- | -- | -- |
| Genky DrugStores Co Ltd | 10.81bn | 400.05m | 7.46bn | 1.84k | 18.34 | 2.49 | 10.04 | 0.6898 | 256.34 | 256.34 | 6,928.04 | 1,891.26 | 1.66 | 6.05 | 47.17 | 114,768,600.00 | 6.15 | 5.34 | 9.42 | 8.48 | 20.47 | 20.47 | 3.70 | 3.22 | 0.2809 | 48.77 | 0.3793 | 6.99 | 8.62 | 10.19 | 11.73 | 20.73 | 6.54 | 0.7875 |
| MedPlus Health Services Ltd | 5.64bn | 178.65m | 8.85bn | 25.00k | 49.55 | -- | 21.42 | 1.57 | 17.25 | 17.25 | 544.80 | -- | -- | -- | -- | 2,615,076.00 | -- | 3.44 | -- | 4.32 | 26.24 | 22.31 | 3.17 | 1.83 | -- | 2.67 | -- | 0.00 | 9.09 | 16.41 | 129.59 | 133.19 | 14.50 | -- |
Data as of Feb 13 2026. Currency figures normalised to Fangzhou Inc's reporting currency: Hong Kong Dollar HKD
0.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 775.00k | 0.06% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 280.00k | 0.02% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 105.00k | 0.01% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 94.00k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 63.00k | 0.01% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 50.50k | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 49.00k | 0.00% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 19.50k | 0.00% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 19.00k | 0.00% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
